NSE filing, NSE: BAJAJHCARE. Summary written from the filing by ALFA Finder's alert engine.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹312.65
- Market cap
- ₹1,053 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 51.1×Sector 46.1×
- Promoter holding
- 58.59%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Earnings Call Transcript: Key Takeaways
Bajaj Healthcare delivered strong H1 growth led by a 82% surge in formulations and key new specialty launches.
- Call
- Guides 15% growth
Bajaj Healthcare Results Update
Bajaj Healthcare reported Q2 FY27 revenue of ₹175.9 Crore, up 18.9% YoY. EBITDA stood at ₹32.1 Crore, reflecting a 12.2% YoY increase.
Bajaj Healthcare Other Announcement
Bajaj Healthcare filed its Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations for the utilization of preferential issue proceeds.
Bajaj Healthcare Q2 FY27 Results: Net Profit ₹14.1 Cr, Up 27.0% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹175.9 Cr (+18.9% YoY) and net profit of ₹14.1 Cr (+27.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹14.1 Cr · +27.0% YoY
Bajaj Healthcare Acquisition
Bajaj Healthcare received NCLT approval to acquire Genrx Pharmaceuticals Private Limited as a going concern. The entity will become a wholly owned subsidiary.
Bajaj Healthcare Merger & Restructuring Worth ₹14.67 Cr
Bajaj Healthcare Limited has executed a deed of assignment to sell its undertaking located in Dahej Industrial Area, Gujarat, for approximately Rs. 14.67 Crore.
- Value
- ₹14.67 Cr
Other board meeting date announcements
All →Jattashankar Industries Board Meeting Date
Jattashankar Industries will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after results are announced.
Aptech Board Meeting Date
Aptech will hold a board meeting on November 4, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after the results are declared.
McNally Bharat Engineering Company Board Meeting Date
McNally Bharat will hold a board meeting on November 12, 2026 to approve unaudited September quarter results. The trading window stays closed until 48 hours after submission.
Shiprocket Board Meeting Date
Shiprocket will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the half year ended September 2026. The trading window stays closed until 48 hours after the outcome is declared.
Seamec Board Meeting Date
Seamec's board meets on 3 November 2026 to consider unaudited quarterly results. The results are not yet approved.
S P Capital Financing Board Meeting Date
SP Capital Financing will hold a board meeting on 4 November 2026 to consider Q2 and half-year results and an interim dividend. The record date for the interim dividend is 13 November 2026.